Sharing information with shareholders, Sun Pharmaceutical Industries
Managing Director Dilip Shanghvi said the company's strategy of
developing the specialty business as an additional growth engine has
started delivering results, with a gradual ramp up in specialty
revenues.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-bullish-on-specialty-biz-looks-to-expand-the-segment-to-new-geographies/articleshow/78344062.cms
No comments:
Post a Comment